Search research articles
Contact Us
Filters
Showing results (1-10 of 253) with videos related to
Page
of 26
Sort By:
Annals of Surgical Oncology
|
November 20, 2019
ASO Author Reflections: The Prognostic Role of Exosomal PD-L1 in Patients with Gastric Cancer
Yibo Fan, Yunpeng Liu, Xiujuan Qu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 26, 2018
Reply to M.F. Chong et al
Lingyun Zhang, Xiujuan Qu, Yunpeng Liu
Frontiers in Oncology
|
January 24, 2022
Editorial: Advances in the Molecular Mechanisms in Gastrointestinal Tumorigenesis and Treatment
Ruowen Zhang, Yu Zhang, Xiujuan Qu
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
July 19, 2021
[Research Progress of Adverse Events Related to PD-1/PD-L1 Inhibitors Based Combination Therapy]
Xiaoyu Guo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research : CR
|
January 18, 2024
Correction: Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research : CR
|
January 3, 2024
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Frontiers in Pharmacology
|
August 29, 2022
Case Report: Fluzoparib for multiple lines of chemotherapy refractory in metastatic cutaneous squamous cell carcinoma with BRCA2 pathogenic mutation
Xin Sun, Wenjuan Chen, Xiujuan Qu, et al.
International Journal of Biological Sciences
|
December 9, 2025
Unravelling Resistance: Integrating Metabolism, Epigenetics, Immunology, and Proteostasis in Strategies against Kirsten Rat Sarcoma Viral Oncogene Homolog-mutant Colorectal Cancer
Jingyi Li, Na Song, Rui Ma, et al.
Journal of Cancer Research and Clinical Oncology
|
November 9, 2023
Multi-targeted tyrosine kinase inhibitor reverses resistance to immunotherapy in hepatic sarcomatoid carcinoma
Juan Chen, Wenjuan Chen, Xiujuan Qu, et al.
Theranostics
|
January 9, 2026
Piezoelectric Heterojunction-driven Biomedical Revolution: From Construction Principles to Diagnostic and Therapeutic Applications
Zhiguang Chen, Wei Zhang, Xiujuan Qu, et al.
Page
of 26
Search research articles
Search
Showing results (1-10 of 253) with videos related to
Sort By:
Page
of 26
Annals of Surgical Oncology
|
November 20, 2019
ASO Author Reflections: The Prognostic Role of Exosomal PD-L1 in Patients with Gastric Cancer
Yibo Fan, Yunpeng Liu, Xiujuan Qu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 26, 2018
Reply to M.F. Chong et al
Lingyun Zhang, Xiujuan Qu, Yunpeng Liu
Frontiers in Oncology
|
January 24, 2022
Editorial: Advances in the Molecular Mechanisms in Gastrointestinal Tumorigenesis and Treatment
Ruowen Zhang, Yu Zhang, Xiujuan Qu
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
July 19, 2021
[Research Progress of Adverse Events Related to PD-1/PD-L1 Inhibitors Based Combination Therapy]
Xiaoyu Guo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research : CR
|
January 18, 2024
Correction: Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research : CR
|
January 3, 2024
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Frontiers in Pharmacology
|
August 29, 2022
Case Report: Fluzoparib for multiple lines of chemotherapy refractory in metastatic cutaneous squamous cell carcinoma with BRCA2 pathogenic mutation
Xin Sun, Wenjuan Chen, Xiujuan Qu, et al.
International Journal of Biological Sciences
|
December 9, 2025
Unravelling Resistance: Integrating Metabolism, Epigenetics, Immunology, and Proteostasis in Strategies against Kirsten Rat Sarcoma Viral Oncogene Homolog-mutant Colorectal Cancer
Jingyi Li, Na Song, Rui Ma, et al.
Journal of Cancer Research and Clinical Oncology
|
November 9, 2023
Multi-targeted tyrosine kinase inhibitor reverses resistance to immunotherapy in hepatic sarcomatoid carcinoma
Juan Chen, Wenjuan Chen, Xiujuan Qu, et al.
Theranostics
|
January 9, 2026
Piezoelectric Heterojunction-driven Biomedical Revolution: From Construction Principles to Diagnostic and Therapeutic Applications
Zhiguang Chen, Wei Zhang, Xiujuan Qu, et al.
Page
of 26